Kroger's board of directors declared a quarterly dividend of 16.5 cents per share to be paid on March 1, to shareholders of record as of the close of business on Feb. 15.
Ahold on Thursday announced consolidated net sales of €7.5 billion (U.S. $10.2 billion) for fourth quarter 2013, a decrease of 1.1% at constant exchange rates compared to fourth quarter 2012.
McKesson may take another bite of the Celesio apple, suggested Sterne Agee analyst Greg Bolan in a note published Monday.
Three drug makers are looking into buying Pfizer's branded-generics drug business, according to published reports.
Diplomat has acquired a hemophilia-focused specialty pharmacy based in Connecticut, the specialty pharmacy company said Monday.
Target is offering free credit monitoring for a year for customers who shop at its stores, the mass merchandise retailer said Monday.
McKesson on Monday announced that it was unsuccessful in reaching the 75% completion condition in its offer for the outstanding shares and convertible bonds of Celesio.
Merck on Monday reported on its intent to explore strategic options for its animal health and consumer care businesses.
Kmart's same-store sales have taken a tumble this quarter as its parent company says it is continuing to focus on transforming itself into a retailer focused on members of its loyalty card program.
Customers' mailing addresses, names, phone numbers and email addresses were among the data stolen as part of a massive breach of payment card data at Target, the mass merchandise retailer said Friday.
The board of directors of Walgreens on Thursday declared a regular quarterly dividend of 31.5 cents per share, a 14.5% increase over the year-ago dividend.
Costco Wholesale Corp.'s sales increased by 6% in the month of December and the first few days of January compared with December 2012, the club retailer said.
Forest Labs will buy privately owned drug maker Aptalis for $2.9 billion, Forest said Thursday.
Family Dollar reported sales of $2.5 billion in first quarter 2014, a 3.2% increase over the same period last year, the dollar store chain said.
While Save-A-Lot is still the jewel in the crown of Supervalu, the chain has committed to investing into its retail supermarket banners with a makeover for all of the banners, a review of the planograms within those banners and private label.
McKesson is preparing to offer concessions to hedge fund Elliott to save its planned acquisition of Celesio, Reuters reported Wednesday morning, citing people familiar with the deal.
Walgreens is not only completely transforming its drug store business from a prescription medicine dispensary to healthcare provider, they're continuing to deliver shareholder value.
Ani Pharmaceuticals has bought 31 generic drugs from Teva Pharmaceuticals for $12.5 million, the company said.
Walgreens reported December sales of $7.2 billion, an increase of 7.2%. Sales in comparable stores increased by 6.1% in December.
IMS Health is looking to go public, the healthcare industry research and analytics company said.
Rite Aid reported a 2.9% increase in same-store sales for the month of December, the retail pharmacy chain said Friday.
Salix Pharmaceuticals has completed its $2.6 billion acquisition of Santarus, Salix said.
A new mobile app-driven social network devoted to medical marijuana has attracted $150,000 in seed money from an investment group.
The security blogger who broke the news about a massive breach of payment card data at Target stores may have identified someone who's been selling the data.
Drug maker Shire is extending the deadline for its offer to buy Exton, Pa.-based ViroPharma for $4.2 billion, Shire said Friday.